John McNeur, diagnosed with stage four pancreatic cancer, is creating a guide to help others navigate the disease in the Northern Territory. He emphasizes living with and beyond cancer, sharing advice on seeking medical help, personal planning, and mental health.
Revolution Medicines' experimental drug, daraxonrasib, has shown unprecedented success in treating advanced pancreatic cancer, doubling patient survival rates and significantly reducing the risk of death by 60% compared to standard chemotherapy. The drug, a first-in-class RAS(ON) inhibitor, targets specific RAS gene mutations and demonstrated a remarkable improvement in tumor shrinkage and patient quality of life, with a much lower incidence of severe side effects. The FDA has granted it expanded access and speedy review.
Daraxonrasib, a new drug targeting the RAS gene, doubles survival time for pancreatic cancer patients compared to chemotherapy, also improving quality of life with fewer severe side effects.
Six Flags Great Adventure is building a record-breaking roller coaster, set to open next year, in partnership with Project Purple to raise awareness and funds for pancreatic cancer research.
A new drug, daraxonrasib, has shown unprecedented results in treating metastatic pancreatic cancer, doubling patient survival rates in a Phase III trial. This breakthrough targets the previously 'undruggable' RAS oncogene, offering new hope for a disease with historically poor outcomes.
A clinical trial in the US shows promising results as a genetically modified virus has stopped pancreatic cancer in three patients. The virus replicates inside tumors, causing them to burst and release more virus to infect neighboring cancer cells. Further trials are needed to determine optimal dosage and effectiveness.
An early US trial shows a genetically modified virus injected directly into pancreatic tumors stopped growth and spread in 3 patients. Researchers are optimistic, noting the low dose used yielded unexpected results, though more research with larger groups is needed.
The US Academy of Sciences has revalidated Mariano Barbacid's study on triple therapy for pancreatic cancer, publishing it identically after a temporary administrative withdrawal. Barbacid refutes claims of scientific flaws, attributing the initial retraction to administrative issues regarding stock ownership and criticizes media attempts to discredit the research.
A Yale University study in mice suggests that different fatty acids have contrasting effects on pancreatic cancer. Omega-3 rich fish oil was linked to lower disease burden, while monounsaturated fatty acids like oleic acid were associated with faster tumor progression.
Cancer claims 10 million lives annually, with varying deadliness. New drugs show promise for pancreatic and head/neck cancers, and precision medicine is advancing. However, a global shortfall of 100 million healthcare workers by 2050 and treatment delays are critical issues. Worryingly, cancer rates are rising in those under 50, linked to environmental factors.
Newspapers report on a pancreatic cancer pill doubling survival times, Dua Lipa's surprise wedding to Callum Turner, and government documents on Lord Mandelson's security concerns. Labour faces warnings of losing working-class support, while new research reclassifies rock markings as prehistoric cave paintings.
A recent study indicates a rising incidence of pancreatic cancer in individuals aged 15-39, with an annual growth rate of 4.35%. Dr. Huang Xuan advises adopting healthy lifestyle habits to mitigate risks.
Ten years after Jack Andraka's viral science fair project on pancreatic cancer detection, the story's intrigue persists. While based on the real biomarker mesothelin, experts caution that a potential discovery doesn't automatically equate to a reliable clinical test, highlighting the gap between a promising idea and a proven medical tool.
Reed Jobs' venture capital fund, Yosemite, managing over $1bn, is seeking UK investment for oncology startups. Inspired by his father Steve Jobs' death, the fund focuses on gene therapy, cancer vaccines, and AI to make cancer treatable.
Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have more reason to hope than ever before.
Mayo Clinic developed AI model REDMOD that detects pancreatic cancer up to 3 years before clinical diagnosis by analyzing routine CT scans, achieving 88% specificity. The system identified cancer an average of 475 days early and was nearly 3 times more accurate than radiologists for cases detected over 2 years before diagnosis.
Tim Cook is stepping down as Apple CEO after 15 years, leaving behind a $4 trillion company that grew from $350 billion in 2011. At age 65, Cook will become executive chair of the board, with John Ternus, 50, senior vice president of hardware engineering, taking over as CEO. Cook joined Apple in 1998, took over as CEO in 2011 after Steve Jobs' medical leave, and oversaw the growth of iPhone, iPad, Apple Watch, AirPods, and services like Apple Pay and Apple Music. The company became the first publicly traded company to reach $1 trillion valuation under his leadership.
Revolution Medicines reported that its drug daraxonrasib significantly extended survival in a Phase 3 pancreatic cancer trial, reducing death risk by 60%. The company plans to seek FDA approval following these results, which saw shares jump over 30%.
